INTERSPECIES SCALING OF CIMETIDINE THEOPHYLLINE PHARMACOKINETIC INTERACTION - INTERSPECIES SCALING IN PHARMACOKINETIC INTERACTIONS

被引:25
作者
GASCON, AR
CALVO, B
HERNANDEZ, RM
DOMINGUEZGIL, A
PEDRAZ, JL
机构
[1] UNIV BASQUE COUNTRY,PHARM & PHARMACEUT TECHNOL LAB,VITORIA,SPAIN
[2] UNIV SALAMANCA,DEPT PHARM & PHARMACEUT TECHNOL,E-37008 SALAMANCA,SPAIN
关键词
INTERSPECIES SCALING; DRUG INTERACTIONS; THEOPHYLLINE; CIMETIDINE;
D O I
10.1023/A:1018914816137
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The aim of the present study was the use of an interspecies scaling approach to predict drug interactions during preclinical drug disposition studies. Theophylline and cimetidine were selected because of their documented interaction. The literature was searched for pharmacokinetic data of intravenously administered theophylline alone and in the presence of cimetidine in humans, dogs and rats. Further, we determined the theophylline-cimetidine drug interaction in rabbits. Application of allometric equations to the pharmacokinetic parameters and the conversion of chronological time into pharmacokinetic time allowed us to obtain the complex Dedrick plot for theophylline when administered alone or in combination with cimetidine. A superimposable kinetic profile was obtained for the plasma levels of theophylline in all species studied, both with and without cimetidine. From the terminal phase of the curves it is possible to calculate the elimination half-life: 2.69 apolisychrons for theophylline when it is administered alone and 3.86 apolisychrons when it is administered in combination with cimetidine. This 43% increase in t(1/2) is similar to the increase in the elimination half-life of theophylline in humans when it is administered after pretreatment with cimetidine. These results show that an interspecies scaling approach may be useful to predict the effect of interactions in humans from the results obtained in preclinical research with new drugs.
引用
收藏
页码:945 / 950
页数:6
相关论文
共 23 条
[1]  
ADEBAYO GI, 1985, BIOPHARM DRUG DISPOS, V10, P77
[2]   NONCOMPARTMENTAL DETERMINATION OF THE STEADY-STATE VOLUME OF DISTRIBUTION [J].
BENET, LZ ;
GALEAZZI, RL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (08) :1071-1074
[3]   INTERSPECIES PHARMACOKINETIC SCALING AND THE EVOLUTIONARY-COMPARATIVE PARADIGM [J].
BOXENBAUM, H .
DRUG METABOLISM REVIEWS, 1984, 15 (5-6) :1071-1121
[4]   INTERSPECIES VARIATION IN LIVER WEIGHT, HEPATIC BLOOD-FLOW, AND ANTIPYRINE INTRINSIC CLEARANCE - EXTRAPOLATION OF DATA TO BENZODIAZEPINES AND PHENYTOIN [J].
BOXENBAUM, H .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1980, 8 (02) :165-176
[5]   INTERSPECIES SCALING, ALLOMETRY, PHYSIOLOGICAL TIME, AND THE GROUND PLAN OF PHARMACOKINETICS [J].
BOXENBAUM, H .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1982, 10 (02) :201-225
[6]  
BOXENBAUM H, 1983, AM J PHYSIOL, V245, P768
[7]   CIMETIDINE-THEOPHYLLINE INTERACTION - EFFECTS OF AGE AND CIMETIDINE DOSE [J].
COHEN, IA ;
JOHNSON, CE ;
BERARDI, RR ;
HYNECK, ML ;
ACHEM, SR .
THERAPEUTIC DRUG MONITORING, 1985, 7 (04) :426-434
[8]  
GASCON AR, IN PRESS IND FARMACE
[9]   INTERSPECIES METABOLISM AND PHARMACOKINETIC SCALING OF THEOPHYLLINE DISPOSITION [J].
GASPARI, F ;
BONATI, M .
DRUG METABOLISM REVIEWS, 1990, 22 (2-3) :179-207
[10]  
Gibaldi M., 1982, PHARMACOKINETICS, Vsecond